Park Ha Biological Technology Co Ltd (BYAH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Park Ha Biological Technology Co Ltd (BYAH) is between -- to -- according to relative valuation method.

Relative Value

Fair Zone

-----

Current Price：1.62

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Park Ha Biological Technology Co Ltd (BYAH) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Park Ha Biological Technology Co Ltd (BYAH) has a current Price-to-Book (P/B) ratio of 1.18. Compared to its 3-year average P/B ratio of 2.17, the current P/B ratio is approximately -45.87% higher. Relative to its 5-year average P/B ratio of 2.17, the current P/B ratio is about -45.87% higher. Park Ha Biological Technology Co Ltd (BYAH) has a Forward Free Cash Flow (FCF) yield of approximately 12.10%. Compared to its 3-year average FCF yield of 9.49%, the current FCF yield is approximately 27.50% lower. Relative to its 5-year average FCF yield of 9.49%, the current FCF yield is about 27.50% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for BYAH competitors is 0.07, providing a benchmark for relative valuation. Park Ha Biological Technology Co Ltd Corp (BYAH.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of BYAH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of BYAH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is BYAH currently overvalued or undervalued?

What is Park Ha Biological Technology Co Ltd (BYAH) fair value?

BYAH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Park Ha Biological Technology Co Ltd (BYAH) is between to according to relative valuation method.

How does BYAH's valuation metrics compare to the industry average?

The average P/S ratio for BYAH's competitors is 0.07, providing a benchmark for relative valuation. Park Ha Biological Technology Co Ltd Corp (BYAH) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Park Ha Biological Technology Co Ltd (BYAH) as of Mar 05 2026?

As of Mar 05 2026, Park Ha Biological Technology Co Ltd (BYAH) has a P/B ratio of 1.18. This indicates that the market values BYAH at 1.18 times its book value.

What is the current FCF Yield for Park Ha Biological Technology Co Ltd (BYAH) as of Mar 05 2026?

As of Mar 05 2026, Park Ha Biological Technology Co Ltd (BYAH) has a FCF Yield of 12.10%. This means that for every dollar of Park Ha Biological Technology Co Ltd's market capitalization, the company generates 12.10 cents in free cash flow.

What is the current Forward P/E ratio for Park Ha Biological Technology Co Ltd (BYAH) as of Mar 05 2026?

As of Mar 05 2026, Park Ha Biological Technology Co Ltd (BYAH) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Park Ha Biological Technology Co Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Park Ha Biological Technology Co Ltd (BYAH) as of Mar 05 2026?

As of Mar 05 2026, Park Ha Biological Technology Co Ltd (BYAH) has a Forward P/S ratio of 0.00. This means the market is valuing BYAH at $0.00 for every dollar of expected revenue over the next 12 months.

BYAH Valuation